Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Kanahia Laniflora Methanolic Extract Suppressed Proliferation of Human Non-Small Cell Lung Cancer A549 Cells

  • Published : 2016.10.01
⟨ Previous Next ⟩

Abstract

Introduction: Lung cancer is one of the most common cancers worldwide. In certain countries such as United States of America, it is the leading cause of related cancer mortality among both men and women. Natural products play an important role in overcoming the limitations of chemotherapy and radiotherapy. Objectives: In this study, we investigated the antiproliferative and apoptotic activities of Kanahia laniflora methanolic extract against human non-small cell lung cancer cells (A549). Methods: Sulforhodamine B colorimetric assays were used to determine the inhibitory effects of a leaf methanolic extract against A549 cells. Results: The extract showed strong cytotoxic activity against A549 cells with an $IC_{50}$ value of $0.13{\mu}g/ml$ compared to $0.21{\mu}g/ml$ for doxorubicin. The extract also significantly increased the percentage of apoptotic cells to 49.7% as compared to 1.4% and 47.4% for control and doxorubicin respectively. Conclusion: These results showed, for the first time, that a methanolic extract of Kanahia laniflora leaves can inhibit the proliferation of human non-small cell lung cancer cells (A549). Further attention to its potential as a new effective anticancer agent is warranted.

Keywords

References

  1. Al-Musayeib NM, Mothana RA, Matheeussen A, et al (2012). In vitro antiplasmodial, antileishmanial and antitrypanosomal activities of selected medicinal plants used in the traditional Arabian Peninsular region. BMC Complement Altern Med, 12, 49.
  2. Al Wadie HM (2007). Plant communites in Wadi Ayaa southwestern Saudi Arabia. J Exp Biol, 3, 1-8.
  3. Alhazmi MI, Hasan TN, Shafi G, et al (2014). Roles of p53 and caspases in induction of apoptosis in MCF- 7 breast cancer cells treated with a methanolic extract of Nigella sativa seeds. Asian Pac J Cancer Prev, 15, 9655-60. https://doi.org/10.7314/APJCP.2014.15.22.9655
  4. Baskic D, Popovic S, Ristic P, et al (2006). Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biol Int, 30, 924-32. https://doi.org/10.1016/j.cellbi.2006.06.016
  5. Brunelle JK, Zhang B (2010). Apoptosis assays for quantifying the bioactivity of anticancer drug products. Drug Resist Updat, 13, 172-9. https://doi.org/10.1016/j.drup.2010.09.001
  6. Calderon-Montano JM, Burgos-Moron E, Orta ML, et al (2014). Evaluating the cancer therapeutic potential of cardiac glycosides. Biomed Res Int, 2014.
  7. Clarkson C, Mellor IR, Lambert M, et al (2006). 5alpha-cardenolides from Kanahia laniflora inhibit ionotropic acetylcholine receptors. Planta Medica, 72, 1418-20. https://doi.org/10.1055/s-2006-951704
  8. Clarkson C, Staerk D, Hansen SH, et al (2005). Hyphenation of Solid-Phase Extraction with Liquid Chromatography and Nuclear Magnetic Resonance: Application of HPLC-DADSPE-NMR to Identification of Constituents of Kanahia laniflora. Anal Chem, 77, 3547-53. https://doi.org/10.1021/ac050212k
  9. Elkady A, Hussein R, El-Assouli S (2014). Mechanism of Action of Nigella sativa on Human Colon Cancer Cells: the Suppression of AP-1 and $NF-{\kappa}B$ Transcription Factors and the Induction of Cytoprotective Genes. Asian Pac J Cancer Prev, 16, 7943-57.
  10. Gemechu A, Giday M, Worku A, et al (2013). In vitro Anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis Strains. BMC Complement Altern Med, 13, 291. https://doi.org/10.1186/1472-6882-13-291
  11. Giday M, Teklehaymanot T, Animut A, et al (2007). Medicinal plants of the Shinasha, Agew-awi and Amhara peoples in northwest Ethiopia. J Ethnopharmacol, 110, 516-25. https://doi.org/10.1016/j.jep.2006.10.011
  12. KAMEL EA-R, Sharawy SM, Karakish EAK (2014). Cytotaxonomical investigations of the tribes asclepiadeae and ceropegieae of the subfamily asclepiadoideae-apocynaceae. Pak J Bot, 46, 1351-61.
  13. Khan N, Afaq F, Mukhtar H (2006). Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis, 28, 233-9. https://doi.org/10.1093/carcin/bgl243
  14. Khazir J, Mir BA, Pilcher L, et al (2014). Role of plants in anticancer drug discovery. Phytochem Lett, 7, 173-81. https://doi.org/10.1016/j.phytol.2013.11.010
  15. Kruger A, van der Vijver L (1986). A chemical and biological evaluation of Kanahia laniflora (Asclepiadaceae). Suid-Afrikaanse Tydskrif vir Natuurwetenskap, 5, 46-52. https://doi.org/10.4102/satnt.v5i1.976
  16. Kumar S (2013). Cardiac glycosides as anticancer agent. J Pharm Biomed Sci, 4, 1371-8.
  17. Langevin SM, Kratzke RA, Kelsey KT (2015). Epigenetics of lung cancer. Transl Res, 165, 74-90. https://doi.org/10.1016/j.trsl.2014.03.001
  18. Lee J-W, Kim W, Min B-I, et al (2015). Traditional herbal medicine as an adjuvant treatment for non-small-cell lung cancer: A systematic review and meta-analysis. Eur J Integr Med, 7, 577-85. https://doi.org/10.1016/j.eujim.2015.08.005
  19. Lemjabbar-Alaoui H, Hassan OUI, Yang Y-W, et al (2015). Lung cancer: Biology and treatment options. Biochimica et Biophysica Acta (BBA). Nat Rev Cancer, 1856, 189-210.
  20. Lou C, Wang M, Yang G, et al (2009). Preliminary studies on anti-tumor activity of 2′,4′-dihydroxychalcone isolated from Herba Oxytropis in human gastric cancer MGC-803 cells. Toxicol In Vitro, 23, 906-10. https://doi.org/10.1016/j.tiv.2009.05.002
  21. Monteiro LdS, Bastos KX, Barbosa-Filho JM, et al (2014). Medicinal plants and other living organisms with antitumor potential against lung cancer. Evid Based Complement Alternat Med, 2014.
  22. Mothana R, Gruenert R, Bednarski P, et al (2009). Evaluation of the in vitro anticancer, antimicrobial and antioxidant activities of some Yemeni plants used in folk medicine. Pharmazie, 64, 260-8.
  23. Paydar M, Wong YL, Moharam BA, et al (2013). In vitro anti-oxidant and anti-cancer activity of methanolic extract from Sanchezia speciosa leaves. Pak J Biol Sci, 16, 1212-5. https://doi.org/10.3923/pjbs.2013.1212.1215
  24. Qi F, Li A, Inagaki Y, et al (2010). Chinese herbal medicines as adjuvant treatment during chemo-or radio-therapy for cancer. Biosci Trends, 4, 297-307.
  25. Rapini A, Chase MW, Goyder DJ, et al (2003). Asclepiadeae classification: evaluating the phylogenetic relationships of New World Asclepiadoideae (Apocynaceae). Taxon, 36, 33-50.
  26. Ravinder Singh C, Kathiresan K (2014). Molecular understanding of lung cancers-A review. Asian Pac J Trop Biomed, 4, 35-41.
  27. Ravishankar D, Rajora AK, Greco F, et al (2013). Flavonoids as prospective compounds for anti-cancer therapy. Int J Biochem Cell Biol, 45, 2821-31. https://doi.org/10.1016/j.biocel.2013.10.004
  28. Ribble D, Goldstein NB, Norris DA, et al (2005). A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol, 5, 12-20. https://doi.org/10.1186/1472-6750-5-12
  29. Roleira FM, Tavares-da-Silva EJ, Varela CL, et al (2015). Plant derived and dietary phenolic antioxidants: Anticancer properties. Food Chem, 183, 235-58. https://doi.org/10.1016/j.foodchem.2015.03.039
  30. Safarzadeh E, Sandoghchian Shotorbani S, Baradaran B (2014). Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull, 4, 421-7.
  31. Seifu T, Asres K, Gebre-Mariam T (2006). Ethnobotanical and ethnopharmaceutical studies on medicinal plants of Chifra District, Afar Region, Northeastern Ethiopia. Ethiopian J Pharm, 24, 41-58.
  32. Shoeb M (2006). Anticancer agents from medicinal plants. Bangladesh J Pharm, 1, 35-41.
  33. Skehan P, Storeng R, Scudiero D, et al (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst, 82, 1107-12. https://doi.org/10.1093/jnci/82.13.1107
  34. Squier MK, Cohen JJ (2001). Standard quantitative assays for apoptosis. Mol Biotechnol, 19, 305-12. https://doi.org/10.1385/MB:19:3:305
  35. Teh E, Belcher E (2014). Lung cancer: diagnosis, staging and treatment. Surgery, 32, 242-8.
  36. Vichai V, Kirtikara K (2006). Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc, 1, 1112-6. https://doi.org/10.1038/nprot.2006.179
  37. Wood SL, Pernemalm M, Crosbie PA, et al (2015). Molecular histology of lung cancer: From targets to treatments. Cancer Treat Rev, 41, 361-75. https://doi.org/10.1016/j.ctrv.2015.02.008